rs201047984
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001134363.3(RBM20):c.1093G>A(p.Gly365Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000282 in 1,550,684 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001134363.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM20 | NM_001134363.3 | c.1093G>A | p.Gly365Arg | missense_variant | Exon 2 of 14 | ENST00000369519.4 | NP_001127835.2 | |
RBM20 | XM_017016103.3 | c.928G>A | p.Gly310Arg | missense_variant | Exon 2 of 14 | XP_016871592.1 | ||
RBM20 | XM_017016104.3 | c.709G>A | p.Gly237Arg | missense_variant | Exon 2 of 14 | XP_016871593.1 | ||
RBM20 | XM_047425116.1 | c.709G>A | p.Gly237Arg | missense_variant | Exon 2 of 14 | XP_047281072.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000810 AC: 126AN: 155630Hom.: 2 AF XY: 0.00106 AC XY: 87AN XY: 82312
GnomAD4 exome AF: 0.000294 AC: 411AN: 1398356Hom.: 5 Cov.: 32 AF XY: 0.000403 AC XY: 278AN XY: 689484
GnomAD4 genome AF: 0.000171 AC: 26AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74488
ClinVar
Submissions by phenotype
not provided Uncertain:1
Gly365Arg (GGG>AGG):c.1093 G>A in exon 2 of the RBM20 gene (NM_001134363.1). The Gly365Arg variant in the RBM20 gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. Gly365Arg results in a non-conservative amino acid substitution of a non-polar Glycine with a positively-charged Arginine at a position that is conserved across species. In silico analysis predicts Gly365Arg is probably damaging to the protein structure/function. Gly365Arg was absent from the 1000 Genomes database, and the NHLBI ESP Exome Variant Server reports Gly365Arg was not observed in approximately 2000 samples from individuals of European and African American backgrounds, indicating it is not a common benign variant in these populations. However, data from ethnically-matched control individuals were not available to assess for a population-specific benign variant. In addition, there are no mutations reported near Gly365Arg indicating this region of the protein may be tolerant of change. With the clinical and molecular information available at this time, we cannot definitively determine if Gly365Arg is a disease-causing mutation or a rare benign variant. The variant is found in DCM panel(s). -
not specified Benign:1
p.Gly365Arg in exon 2 of RBM20: This variant is not expected to have clinical si gnificance because it has been identified in 0.5% (119/22735) of South Asian chr omosomes, including 2 homozygotes, by the Genome Aggregation Database (gnomAD, h ttp://gnomad.broadinstitute.org/; dbSNP rs201047984). -
Dilated cardiomyopathy 1DD Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at